Kendall
Kendall v. Odonate Therapeutics, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 13 KEVIN KENDALL, individually and on Case No.: 3:20-cv-01828-H-LL behalf of all others similarly situated,
AMENDED ORDER:
Plaintiff, 16 v. (1) CERTIFYING CLASS FOR
SETTLEMENT PURPOSES;
ODONATE THERAPEUTICS, INC.,
KEVIN C. TANG, MICHAEL HEARNE,
(2) PRELIMINARILY APPROVING JOHN G. LEMKEY,
CLASS SETTLEMENT;
Defendants.
(3) APPOINTING CLASS
REPRESENTATIVE AND CO-
COUNSEL;
23 (4) APPROVING CLASS NOTICE; 24 and 25 (5) SCHEDULING FINAL
APPROVAL HEARING
27 [Doc. No. 43.] 28 On December 3, 2022, Plaintiff Kevin Kendall filed an unopposed motion for preliminary approval of class action settlement and directing dissemination of notice to the class. (Doc. No. 43.) On January 3, 2022, Defendants Odonate Therapeutics, Inc., Kevin C. Tang, Michael Hearne, John G. Lemkey (collectively, “Defendants”) filed a notice of non-opposition to Plaintiff’s motion. (Doc. No. 46.) The Court held a hearing on the matter…